Member Info for Latino

Should see an RNS today confirming opening..

Looks likes bottom hit, shorters exiting...?

On the rise..

It appears on the same trajectory...let’s see!

Ivy / Hasiba,

Any of you have an opinion on the significance of this 10th May date...?

- The terms of the Hercules Agreement are effective immediately, except for provisions of a release that relate to the pledge of Motif Bio's interest in Motif Inc. which will become effective no later than 10 May 2020, being approximately 100 days after Hercules's security interest in all of the intellectual property of Motif Inc. is perfected, provided that no voluntary or involuntary bankruptcy filing has occurred with respect to Motif Bio or Motif Inc.

H - informed post once again.

Now if anybody does want to know about Iclaprim and it’s development, then you really want to be asking people like H - knows this product and it’s development inside out, and of course the past and utter and useless BoD!

M - just pasted this from the web ‘stating yesterday FDA vote’...unfortunately he just pasted this of the web article dated from 2018 which was Arpida back then - busted and I did say flawed research - credibility shot to zero!

https://www.fiercebiotech.com/biotech/arpida-comments-on-fda-s-anti-infective-drugs-advisory-committee-outcome

My word...you seriously don’t have a clue! Back to school..

Exactly my point...dermapers have no research behind them so keep dismissing iclaprim.

Nope never refused it...they said they want more data!

Importantly, FDA also must take some blame for this companies demise. Took company some good part of a year just to have a series of 3 meeting with FDA to understand what their requirements were to approve Iclaprim...takes like for 4 months to arrange, execute and get their minutes for a single meeting. It’s only after 3/4 meeting that company realised they actually wanted another small trial...

Just telling you the facts of what actually happened...valuation based on just cash is flawed...why can you not see this???

Yeah right, you’re still wrong as that share never ever hit 5p yet lol

It hit 100p, and lowest after rise (your posts) was 16p...so even years after you said this the SP still sitting at 30p now.

So time to reflect, your valuation based on just cash is flawed...

I’ve blown em away! Remember knowledge is power..

...and there is also now the FDA EUA approvals which can fastrack a trial on COVID19 patients if the buying Pharma company can demonstrate its effectiveness...it does not have to be iclaprim on its own it can part of a ‘****tail of drugs’....see recent TILS announcement there are merging an antibiotic with their IL6 drug!

..plus of course time and efforts which could runs into many number of years stretching from 5-10yrs on average.

Agree Iclaprim has merit and US military scientists see this hence the trial. It’s one more restricted phase 3 trial away from full FDA approval (roadmap already agreed with FDA).

So any pharma company buying Iclaprim, will significantly save on on the years and risk of development cost and approval costs with FDA...this saving 10s of $m’s in the process!

It’s all nonsense...who spends hours and days on a stock their not interested in...find that rather hard to believe even with my blinkers on!

Lol - that’s what dermapers do..! Dismiss existing assets and focus on placing to discredit the SP. Maybe research how many millions on average it cost to develop a drug from pre-clinical to Phase 1, Phase 2, and then Phase 3 (that’s if you get there)...try a figure over over $20m on average!

Ignore Iclaprim at your peril...in the current COVID19 pandemic this may have a crucial role to play for secondary therapeutics..

No asset lol They have Iclaprim worth at least over $10m, already in phase 3 trials!